Online citations, reference lists, and bibliographies.
← Back to Search

SALL4 Suppresses Reactive Oxygen Species In Pancreatic Ductal Adenocarcinoma Phenotype Via FoxM1/Prx III Axis.

D. Huynh, J. Zhang, Nisansala Chandimali, M. Ghosh, M. Gera, Nameun Kim, Yang-Ho Park, Taeho Kwon, D. Jeong
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Pancreatic ductal adenocarcinoma (PDAC) is a major malignant phenotype in pancreatic cancer, which is one of the most death causes by cancer in the world. PDAC developed from pancreatic intra-epithelial neoplasms (PanINs) and poorly diagnosed at early stages. Beside of high drug resistance, metastasis is the great concern during pancreatic cancer treatment. SALL4 expression is inherent in the upregulations of endothelial mesenchymal transition (EMT) genes and therefore promoting cancer metastasis. Furthermore, some of evidences indicated reactive oxygen species (ROS) is also influent to metastasis and self-antioxidant capacity seems a gold standard for successful metastasis rate. In this study, we have found the role Spalt like protein 4 (SALL4) to PDAC proliferation, mobility and its regulation to mitochondrial ROS via FoxM1/Prx III axis. It is possible that SALL4 mainly induces endothelial-mesenchymal transition (EMT) phenotype and favors ROS loss to facilitate metastasis efficiency in PDAC cells. Therefore, SALL4 might be a promising marker for PDAC treatment and targeting SALL4 would benefit anti-proliferative and anti-metastasis therapies.
This paper references
10.1074/JBC.M407707200
Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria*
T. Chang (2004)
10.1172/JCI43144
Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling.
Y. Qu (2011)
10.1186/1423-0127-20-6
Role of SALL4 in the progression and metastasis of colorectal cancer
M. M. Forghanifard (2013)
10.1016/j.fob.2012.12.002
Anti-apoptotic role of peroxiredoxin III in cervical cancer cells☆
Lianqin Li (2012)
10.1038/bjc.2013.396
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
H. Whitaker (2013)
10.1089/ars.2012.4713
SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC-1α complex.
Y. Olmos (2013)
10.1016/j.febslet.2013.07.049
Sal‐like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal‐like breast cancer
J. Itou (2013)
10.1038/cddis.2013.20
Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis
S. Kamarajugadda (2013)
10.1038/onc.2013.495
SALL4, a novel marker for human gastric carcinogenesis and metastasis
L. Zhang (2014)
10.3109/10428194.2014.924115
MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia
Wenjie Jiang (2014)
10.2174/1381612821666141211115234
Pancreatic cancer metastasis: are we being pre-EMTed?
Srustidhar Das (2015)
10.1038/nature15726
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova (2015)
10.1038/onc.2013.529
SALL4 is a new target in endometrial cancer
Ailing Li (2013)
10.1016/j.canlet.2014.11.037
SALL4: an emerging cancer biomarker and target.
Xu Zhang (2015)
10.1126/scitranslmed.aad3740
Antioxidants can increase melanoma metastasis in mice
K. Le Gal (2015)
10.1016/j.canlet.2014.04.001
The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
J. Lu (2015)
10.1007/s00432-015-1916-3
The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells
Lianqin Li (2015)
10.1053/j.gastro.2015.06.007
FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
I. Song (2015)
10.1016/j.pharmthera.2016.03.018
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
M. H. Park (2016)
10.1038/emm.2016.119
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Jongdoo Kim (2016)
10.1126/scitranslmed.aad6095
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
Hui Wang (2016)
10.1016/j.gene.2016.02.019
SALL4, the missing link between stem cells, development and cancer.
H. Tatetsu (2016)
10.3390/ijms18071338
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
A. Adamska (2017)
10.1101/gad.305805.117
A conduit to metastasis: circulating tumor cell biology.
D. Micalizzi (2017)
10.18632/oncotarget.21580
Peroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress
I. Song (2017)
10.1038/srep39975
High Shear Stresses under Exercise Condition Destroy Circulating Tumor Cells in a Microfluidic System
Sagar Regmi (2017)
10.18632/oncotarget.13838
Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma
Hua Zhang (2016)
10.21873/ANTICANRES.11628
Pancreatic Cancer Stem Cells and Therapeutic Approaches.
G. Ercan (2017)
10.3389/fphys.2017.00381
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
Michael Pimienta (2017)
10.1158/0008-5472.CAN-17-2748
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize.
M. Giuliano (2018)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar